Herbal Dispatch Provides Update on Sold Out Product Launch
Vancouver, British Columbia--(Newsfile Corp. - November 25, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") is pleased to provide a market update on the retail launch of its highly anticipated 2025 Happy Hour Cannabis Advent Calendar, titled "The Twelve Days of Christmas." This limited-edition pre-roll multi-pack box was made available to BC retailers through the Company's Direct Delivery platform and through BC C
Pharmaceuticals, Cannabis, Cannabis Dispensary
2025-11-25 7:00 AM EST | Herbal Dispatch Inc.
Skye Bioscience to Participate in Upcoming Investment Conferences
San Diego, California--(Newsfile Corp. - November 24, 2025) - Skye Bioscience, Inc. (NASDAQ: SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will participate in the following upcoming investment conferences: Citi Global Healthcare Conference (Miami) 1x1 meetings: Dec. 2 Evercore Annual Healthcare Conference (Coral Gables) Fireside Chat: Dec. 3, 12:55 pm
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-11-24 7:00 AM EST | Skye Bioscience, Inc.
CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - November 20, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, issued the following corrected press release, announcing the Company's financial results for the period ended September 30, 2025. In a news release issued earlier today by Vext, the Company identified
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-11-20 4:31 PM EST | VEXT Science, Inc.
Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million
Revenue of $12.7 million, up 41% YoY, driven by expanded Ohio retail operations and continued resilient performance in Arizona. YTD operating cash flow of $8.5 million compared to $(0.7) million in Q3 2024 YTD. Strengthened Ohio retail footprint to five consolidated locations. On track to reach the state dispensary license cap of eight in 20261, positioning Vext to capture sustained growth fro
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-11-20 6:30 AM EST | VEXT Science, Inc.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives Second, Larger 5kg Psilocybin Shipment via USA Controlled Substances Import Permit
Toronto, Ontario--(Newsfile Corp. - November 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws is excited to announce that it has, f
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-11-19 7:45 AM EST | Red Light Holland Corp.
Herbal Dispatch Announces Record-Breaking Month of $4.1M in Sales for October 2025
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company") is pleased to announce a record-breaking month of sales for October 2025 and an updated forecast for the fourth quarter of 2025, reflecting continued positive momentum. In October 2025, the Company achieved gross sales of approximately $4.1 million, marking the highest monthly sales in its history and
Pharmaceuticals, Cannabis, Cannabis Dispensary
2025-11-17 7:00 AM EST | Herbal Dispatch Inc.
RETRANSMISSION: Akanda Researching Security Requirements for Full Cultivation License
Toronto, Ontario--(Newsfile Corp. - November 14, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") is researching the security requirements and next steps for a full cultivation license through its cannabis operating subsidiary. Recently, the Company extended its option on its British Columbia asset for an additional two years. While the Company currently operates under its hemp cultivation license, Akanda plans to advance toward a full cultivation license for a range of potenti
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-11-14 8:30 AM EST | Akanda Corp
Akanda Researching Security Requirements for Full Cultivation License
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") is researching the security requirements and next steps for a full cultivation license through its cannabis operating subsidiary. Recently, the Company extended its option on its British Columbia asset for an additional two years. While the Company currently operates under its hemp cultivation license, Akanda plans to advance toward a full cultivation license for a range of potenti
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-11-13 4:05 PM EST | Akanda Corp
Steep Hill Announces Amalgamation Agreement with Good Purpose Investments
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to announce that it has entered into an amalgamation agreement (the "Amalgamation Agreement") dated effective November 12, 2025, with Good Purpose Investments Inc. ("Good Purpose") and 1561117 B.C. Ltd. ("Subco"), a wholly owned subsidiary of the Company, pursuant to which the Company will, by way of a three-cornered amalgama
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-11-13 10:19 AM EST | Steep Hill Inc.
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040
Once issued, this new U.S. patent covers the use of CardiolRx™ and CRD-38 for a broad range of cardiac disorders, including atherosclerosis and heart failure, significantly expanding intellectual property protection in the world's largest pharmaceutical market. This allowance fortifies Cardiol's global intellectual property portfolio, adding to granted and pending patent applications in Europe, Japan, Canada, Australia, and
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-11-13 7:45 AM EST | Cardiol Therapeutics Inc.
Quinsam Reports Q3/2025 Results
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing its Q3/2025 results, with net income of $0.1 million ($0.00 per share basic, $0.00 fully diluted) versus net income of $1.2 million ($0.01 per share basic, $0.01 fully diluted) in Q3/2024. Investors can access the Company's full financial statements on sedarplus.ca. "While our performance
Banking / Financial Services, Cannabis, Cannabis Cultivator, Cannabis Ancillary Service Provider
2025-11-13 7:30 AM EST | Quinsam Capital Corporation
Red Light Holland's Wholly Owned Subsidiary Happy Caps Expands Safeway Partnership to 123 Stores Across the U.S. Pacific Northwest, in Time for American Thanksgiving
Toronto, Ontario--(Newsfile Corp. - November 11, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, is pleased to announce a major U.S. retail expansion milestone for its wholly owned subsidiary, 4316747 Nova Scotia Limited o/a Happy Caps Mushroom Farm ("Happy Caps") with Albertso
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-11-11 8:39 AM EST | Red Light Holland Corp.
Vext to Announce Financial Results for Q3 2025 on November 20, 2025
Vancouver, British Columbia--(Newsfile Corp. - November 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the third quarter ended September 30, 2025, before market open on November 20, 2025. The Company will host a con
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2025-11-11 7:30 AM EST | VEXT Science, Inc.
Digicann Ventures to Resume Trading on the Canadian Securities Exchange
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2025) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, is pleased to announce that its common shares will resume trading on the Canadian Securities Exchange (the "CSE") on November 11, 2025, under the ticker symbol "DCNN.X". Trading of the securities was halted on September 30, 2024, in connection with the ann
Banking / Financial Services, Cannabis
2025-11-10 9:00 PM EST | Digicann Ventures Inc.
Delivra Health Brands Reports Financial Results for First Quarter of Fiscal 2026 Highlighting Continued Growth of Dream Water (R) and LivRelief(TM)
Growth of Dream Water® US and Canada by 8% compared to same quarter last year Growth of Dream Water® E-commerce by 74% compared to same quarter last year Growth of LivRelief™ by 9% compared to same quarter last year Growth of LivRelief™ E-commerce by 16% compared to same quarter last year Vancouver, British Co
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-11-10 7:25 AM EST | Delivra Health Brands Inc.
C21 Investments to Report Second Quarter Financial Results on November 11, 2025
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced it will release its financial results for the second quarter ended September 30, 2025, on Tuesday, November 11, 2025, before market open. For further inquiries, please contact:
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2025-11-07 7:00 AM EST | C21 Investments Inc.
Nextleaf Announces Launch of New Recreational Cannabis Brand
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce the national launch of its new recreational brand, Yard. Yard is designed for adult-use consumers seeking bold recreational cannabis experiences through high-potency extracts, premium hardware, and flavour-forward formul
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2025-11-06 9:29 AM EST | Nextleaf Solutions Ltd.
Elixxer Ltd. Provides Update and Corrective Statements on Proposed Debt Settlement and Upcoming Shareholder Meeting
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") announces that it has called its annual and special shareholder meeting (the "Meeting") of shareholders of the Company, to be held on Tuesday, December 30, 2025. The management information circular and related materials will be mailed to shareholders of the Company and filed on the Company's profile on SEDAR+ on or about November 25, 2025. At the Meeting
2025-11-06 8:55 AM EST | Elixxer Ltd.
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis. Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular volume and a significant reduction in left ventricular mass. The Company will host a webcast conference call on Decembe
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-11-05 7:45 AM EST | Cardiol Therapeutics Inc.
PharmaDrug Announces Debt Restructuring
Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has agreed to issue $445,686 principal amount of secured convertible debentures to two current holders of the Company's secured convertible debentures that were past their maturity date. Each Debe
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-10-31 8:58 AM EDT | PharmaDrug Inc.